EFFECTS OF ROFLUMILAST N-OXIDE, THE ACTIVE METABOLITE OF THE ORAL, ONCE-DAILY PDE4 INHIBITOR ROFLUMILAST, ON HUMAN CELLS INVOLVED IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN VITRO | Publicación